Akzo Nobel N.V.
AKZOF
$65.80
$2.624.15%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.59B | 11.52B | 11.57B | 11.56B | 11.54B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.59B | 11.52B | 11.57B | 11.56B | 11.54B |
| Cost of Revenue | 6.89B | 6.82B | 6.84B | 6.85B | 6.96B |
| Gross Profit | 4.69B | 4.70B | 4.73B | 4.71B | 4.58B |
| SG&A Expenses | 3.35B | 3.31B | 3.29B | 3.25B | 3.20B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.57M | -17.10M | -73.75M | -68.32M | -65.12M |
| Total Operating Expenses | 10.56B | 10.40B | 10.35B | 10.32B | 10.39B |
| Operating Income | 1.02B | 1.12B | 1.22B | 1.24B | 1.15B |
| Income Before Tax | 909.01M | 915.40M | 963.85M | 961.37M | 849.74M |
| Income Tax Expenses | 266.47M | 256.33M | 276.17M | 334.50M | 320.88M |
| Earnings from Continuing Operations | 642.54 | 659.07 | 687.68 | 626.87 | 528.86 |
| Earnings from Discontinued Operations | -9.30K | -3.24M | -4.33M | -5.40M | -5.39M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -53.94M | -45.49M | -46.50M | -46.68M | -44.37M |
| Net Income | 588.59M | 610.34M | 636.85M | 574.78M | 479.10M |
| EBIT | 1.02B | 1.12B | 1.22B | 1.24B | 1.15B |
| EBITDA | 1.42B | 1.52B | 1.61B | 1.63B | 1.54B |
| EPS Basic | 3.45 | 3.58 | 3.74 | 3.37 | 2.81 |
| Normalized Basic EPS | 3.02 | 3.26 | 3.24 | 3.23 | 2.84 |
| EPS Diluted | 3.44 | 3.57 | 3.72 | 3.36 | 2.80 |
| Normalized Diluted EPS | 3.00 | 3.25 | 3.23 | 3.22 | 2.83 |
| Average Basic Shares Outstanding | 682.36M | 682.16M | 681.96M | 681.86M | 682.30M |
| Average Diluted Shares Outstanding | 688.03M | 683.87M | 684.11M | 684.01M | 684.16M |
| Dividend Per Share | 2.12 | 2.13 | 2.13 | 2.14 | 2.14 |
| Payout Ratio | 61.75% | 60.17% | 59.54% | 65.59% | 77.78% |
